ClinicalTrials.Veeva

Menu

Assessment of Hard and Soft Tissue Changes Following XCM Versus FGG Simultaneous With Dental Implant Placement

Cairo University (CU) logo

Cairo University (CU)

Status

Not yet enrolling

Conditions

Missing Teeth

Treatments

Procedure: Xenogeneic collagen matrix simultaneous with delayed implant placement
Procedure: Free gingival graft simultaneous with delayed implant placement

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Teeth loss are usually associated with alterations of extraction sockets result in obviously absorbed alveolar ridges and are often accompanied with soft tissue atrophy such as narrow keratinized tissue and a shallow vestibule.

Lack of peri-implant keratinized tissue is a potential risk to peri-implant diseases. Although the role of width of KM in maintaining peri-implant health is a controversial topic, the majority of high-level evidence has suggested that a minimum KM width (KMW) of 2 mm around the dental implants is critical to maintain peri-implant health and the long-term survival of dental implants.

Full description

This study will be carried out on patients attending outpatient clinic of Oral maxillofacial surgery and Periodontology Departments, Faculty of Dentistry. Modern University for Technology and Information, Cairo, Egypt.

P: Healthy patients with posterior missing teeth with deficient keratinized tissue to receive delayed dental implant placement I: Xenogeneic collagen membrane (XCM) simultaneous with delayed implant placement C: Free gingival graft (FGG) simultaneous with delayed implant placement O: Keratinized tissue width (KMW), graft shrinkage (GS), marginal bone loss (MBL) T- One year S- Randomized controlled clinical trial.

Eligible patients will be divided into equal proportions between control group and test group.

The control group "Group 1" will receive FGG simultaneous with implant placement The test group "Group 2" will receive XCM simultaneous with implant placement

Enrollment

20 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Adults above the age of 18 years.
  2. Presence of 2mm or less of keratinized tissue width
  3. Sufficient alveolar ridge width minimum of 6 mm
  4. Patients with good oral hygiene as evidenced by plaque index (PI)<1 and showing cooperation or compliance with treatment.

Exclusion criteria

  1. Patients diagnosed with periodontal diseases (Caton et al., 2018).
  2. Acute active infection at implant sites
  3. Patients with medical conditions that would compromise the surgical procedures; uncontrolled diabetes mellitus, taking intravenous bisphosphonates for treatment of osteoporosis and radiotherapy
  4. Patients with parafunctional habits.
  5. Smokers (≥10 cigarettes per day),

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

Xenogeneic collagen matrix simultaneous with delayed implant placement
Experimental group
Description:
Tissue punch technique implants will be placed. XCM grafts (of bovine origin) will be trimmed to the required dimensions and will be fixed to the periosteum and sutured to the buccal peri-implant mucosa
Treatment:
Procedure: Xenogeneic collagen matrix simultaneous with delayed implant placement
Free gingival graft simultaneous with delayed implant placement
Active Comparator group
Description:
Tissue punch technique implants will be placed. A FGG will be harvested from the palate then the outlined graft will be placed and sutured to the recipient bed of the buccal peri-implant mucosa
Treatment:
Procedure: Free gingival graft simultaneous with delayed implant placement

Trial contacts and locations

1

Loading...

Central trial contact

Maged M Seleet, PhD; Parryhan M Abdelsamie, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems